Bambusa Therapeutics Inc. (BBTX)
Snapshot
- 1 week
- +6.7%+8.5% vs SPY
- Market cap
- $796.2M
Signal evidence
Prediction markets
Kalshi · Polymarket · … linked
Company
Bambusa Therapeutics Inc. (BBTX). Bambusa Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It engages in developing a portfolio of next-generation, multi-targeting medicines designed to transform patient care across chronic immunology and inflammation diseases. The company was founded by Shan Shan Xu, Thang Ho, and Helmut Jeggle on March 14, 2024 and is headquartered in Boston, MA.
- Jonathan I. LieberChief Financial Officer
- Wenbing HuVice President & Head of CMC
- Crystal MacKayChief Operating Officer
- Isabelle MuldnerSecretary
- Melody ZhuVice President of Corporate Development & Strategy
Snapshot
Price & returns1 week +6.7%
- 1 week
- +6.7%+8.5% vs SPY
Valuationmarket cap $796.2M
- Market cap
- $796.2M
Signal evidence
Prediction markets
Kalshi · Polymarket · … linked
Company
Bambusa Therapeutics Inc. (BBTX). Bambusa Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It engages in developing a portfolio of next-generation, multi-targeting medicines designed to transform patient care across chronic immunology and inflammation diseases. The company was founded by Shan Shan Xu, Thang Ho, and Helmut Jeggle on March 14, 2024 and is headquartered in Boston, MA.
- Jonathan I. LieberChief Financial Officer
- Wenbing HuVice President & Head of CMC
- Crystal MacKayChief Operating Officer
- Isabelle MuldnerSecretary
